Streetbeat News

Earnings

FHN

First Horizon (NYSE:FHN) reported Q1 earnings of $0.35 per share, surpassing the consensus estimate of $0.34, and sales of $819.00M, beating estimates of $809.19M. However, this represents a 22.22% decrease in earnings and a 4.66% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 10:33 am

CFG

Citizens Financial Group (CFG) reported Q1 adjusted earnings of $0.79 per share, surpassing the consensus estimate of $0.74 by 6.76%. However, earnings decreased by 28.18% from $1.10 per share a year ago. Q1 sales were $1.959 billion, slightly missing the estimate of $1.96 billion by 0.05% and representing a 7.94% decrease from $2.13 billion in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 10:24 am

CFG

Citizens Financial Group reported a Q1 adjusted EPS of $0.79, surpassing the estimated $0.74.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 10:22 am

VFS

VinFast Auto has reaffirmed its target to deliver 100,000 electric vehicles (EVs) in the fiscal year 2024. As of March 31, the company reported having cash and equivalents totaling $123.3 million. This outlook is based on the company's current and preliminary view of the business and market conditions, which may change.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 10:21 am

STLA

Stellantis N.V. (NYSE:STLA) CEO Carlos Tavares warned of a challenging year ahead due to rising prices, raw material costs, and labor disputes. Despite these challenges, shareholders approved the 2023 remuneration report for senior managers with 70% approval. Tavares' compensation faced scrutiny amid cost-cutting and workforce reduction efforts, including voluntary redundancy for 3,000 Italian workers and layoffs in France and the U.S. The company rewarded employees with €1.9 billion for 2023 performance. STLA shares rose 0.35% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

April 17, 2024 | 10:19 am

VFS

VinFast Auto reported Q1 earnings with a loss of $(0.26) per share, missing the consensus estimate of $(0.22). Sales reached $302.65M, marking a 269.7% increase YoY, primarily from EV sales.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 10:18 am

DYNT

INVO

MGAM

YYAO

INVO Bioscience shares surged 73% in pre-market trading after reporting a 397% increase in quarterly revenue. Other stocks also showed significant movement in pre-market trading, with notable gainers including Mobile Global Esports, Chromocell Therapeutics, and Clene Inc., and losers like Connexa Sports Technologies and Dynatronics Corporation.

Portfolio Pulse from Avi Kapoor

April 17, 2024 | 10:13 am

GSK

GSK's EAGLE-1 Phase 3 trial results for gepotidacin show a 92.6% success rate in treating uncomplicated urogenital gonorrhea, positioning it as a potential first-in-class oral antibiotic. This marks the third positive pivotal trial for gepotidacin within GSK's infectious diseases portfolio.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 9:32 am

ABT

ASML

PLD

USB

VFS

Earnings reports for April 17, 2024, include a wide range of companies across various sectors, with projections covering earnings per share and revenue. Notable companies reporting include ASML Holding, VinFast Auto, Prologis, Abbott Laboratories, and U.S. Bancorp before the bell, and Exela Technologies, Las Vegas Sands, Equifax, Alcoa, and CSX after the bell.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 9:15 am

SHLT

SHL Telemedicine reported a fiscal year net loss of $6.9 million, a significant increase from the previous year's loss of $0.4 million.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 9:09 am